Pfizer Canada accepts entries for seventh round of competition for Pfizer CVRAP

- Program offers a number of awards in support of Cardiovascular research in Canada -

Pfizer Canada is currently accepting entries for its seventh round of competition for the Pfizer Cardiovascular Research Awards program (CVRAP). The program, first launched in October 2005, was developed to fund and support independent cardiovascular research in Canada.

The Pfizer CVRAP is open to all researchers interested in cardiovascular disease, including physicians, academics and pharmacists. The awards offer Canadian scientists an opportunity to conduct important research in the area of Cardiovascular disease. Specific awards that have been recently added to the program include:

- The Kidney Foundation of Canada/Pfizer Canada-Cardio-Renal Research Award - The Canadian Hypertension Society/Pfizer Award - The Cardiovascular Health Network - Pfizer Canada Grant for the Future - The Jean Davignon Distinguished Cardiovascular-Metabolic Research Award - The Ontario Lung Association/Pfizer Canada Awards

The competition closes on April 2nd, 2010. Award recipients will be announced at the Canadian Cardiovascular Congress in October 2010 and other selected venues in the Fall. Details on accepted research themes, eligibility and other requirements are available online and proposals can be submitted at www.pfizercv.ca.

"Canadians run a high risk of developing cardiovascular disease as 90 per cent have at least one risk factor for heart disease or stroke," says Dr. Bernard Prigent, Vice President and Medical Director, Pfizer Canada. "Pfizer is committed to improving the cardiovascular health and quality of life of Canadians by investing in the stellar research being conducted by Canadian scientists."

Source: PFIZER CANADA INC.